Robert L. Giuntoli, II, MD
Gynecologic Oncology
Accepting new patients
Sees patients age 12 and up
Abramson Cancer Center West Chester
View 1 additional location
Penn Medicine Provider

About me

  • Medical Director of Surgical Oncology at Penn Medicine Chester County Hospital
  • Director of Gynecologic Oncology Penn Medicine Chester County Hospital
  • Professor of Clinical Obstetrics and Gynecology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Duke University Medical Center
  • Fellowship: Women & Infant's Hospital of Rhode Island
  • Fellowship: Mayo Clinic

What my patients think about me

Average Rating

899 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
February 2026
he is the best!
Anonymous
February 2026
very thorough and kind
Anonymous
February 2026
Dr. Giuntoli wonderfull doctor
Anonymous
February 2026
Dr. G made me feel comfortable and answered all my questions.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Giuntoli is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R 2nd, Glaser G, Glaser S, Howitt BE, Kendra K, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology. , J Natl Compr Canc Netw: 2026,24(3):101-126. doi: 10.6004/jnccn.2026.0011


Jang M, Dagher C, Gysler S, Ko EM, Giuntoli RL 2nd, Martin L, Kim SH, Nasioudis D Incidence of ESR1 gene mutations among patients with endometrioid endometrial cancer. , Int J Gynecol Cancer: 2026,36(2):102816. doi: 10.1016/j.ijgc.2025.102816


Jang M, Gysler S, Ko EM, Giuntoli RL 2nd, Latif NA, Kim SH, Nasioudis D Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit. , Int J Gynecol Cancer.: 2026,36(2):102824. doi: 10.1016/j.ijgc.2025.102824


Dagher C, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM, Nasioudis D Outcomes of patients with metastatic squamous cell carcinoma of the vulva. , Int J Gynecol Cancer: 2026,36(1):102772. doi: 10.1016/j.ijgc.2025.102772


Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R 2nd, Glaser S, Howitt BE, Kendra K, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology. , J Natl Compr Canc Netw. : 2025,23(12):549-573. doi: 10.6004/jnccn.2025.0057


Huang A, Latif NA, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D Outcomes of the sentinel lymph node mapping algorithm for patients with locally advanced endometrial carcinoma. , Int J Gynecol Cancer: 2025,35(12):102651. doi: 10.1016/j.ijgc.2025.102651


Jang M, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Simpkins F, Nasioudis D Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategies. , Gynecol Oncol Rep: 2025,63:102008. doi: 10.1016/j.gore.2025.102008


Cucinella G, Zammarrelli WA 3rd, Nasioudis D, Gabrilovich S, Capasso I, Berretta R, Scollo P, Raspagliesi F, Baiocchi G, Barresi G, Pecorino B, Bogani G, Kurnit KC, De Brot L, Lembo A, Maryam S, Fought AJ, McGree ME, Chiantera V, Bosquet JG, Fanfani F, Scambia G, Abu-Rustum NR, Mariani A, Giuntoli R 2nd, Glaser G, Leitao MM Jr Endometrial carcinosarcoma without myoinvasion. , Int J Gynecol Cancer: 2025,35(10):101971. doi: 10.1016/j.ijgc.2025.101971


Caruso G, Ainio C, Fumagalli D, Reynolds EA, Nasioudis D, Mc Gree ME, Fought AJ, Giuntoli RL, Mariani A, Cliby WA Textbook oncologic outcome in endometrial cancer surgery: A quality measure to improve survival and address disparities. , Gynecol Oncol. : 2025,200:33-43. doi: 10.1016/j.ygyno.2025.07.009


Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. , J Natl Compr Canc Netw: 2025,23(8):284-291. doi: 10.6004/jnccn.2025.0038